Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BMSCs plus PRP for Knee Osteoarthritis
NCT03969680Phase 2Terminated
- Sponsor
- Yantai Yuhuangding Hospital
- Start
- Jul 2019
- Primary completion
- Oct 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of bone marrow-derived mesenchymal stem cells in osteoarthritis (OA), sponsored by Yantai Yuhuangding Hospital. Started Jul 2019; status: terminated.
02
Drugs
bone marrow-derived mesenchymal stem cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03969680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03969680.